# A Study of PEP08 in Patients With MTAP-Del Advanced or Metastatic Solid Tumors

> **NCT06973863** · PHASE1 · RECRUITING · sponsor: **PharmaEngine** · enrollment: 40 (estimated)

## Conditions studied

- Advanced Solid Tumor
- Solid Tumors
- MTAP-deleted Solid Tumors
- MTAP Deletion

## Interventions

- **DRUG:** PEP08

## Key facts

- **NCT ID:** NCT06973863
- **Lead sponsor:** PharmaEngine
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-26
- **Primary completion:** 2027-12
- **Final completion:** 2028-03
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06973863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06973863, "A Study of PEP08 in Patients With MTAP-Del Advanced or Metastatic Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06973863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*